A burgeoning pharmaceutical industry hard-pressed to find treatments and cures for various chronic and other ailments has given rise to the concept of cell banking. With limited capacity to store cells required for research in the field of regenerative medicines, somatic cell therapy, gene therapy, and tissue-engineered products they are increasingly outsourcing it to other entities specializing in it. GMP basically stands for “Good Manufacturing Practice.” A recent report on GMP cell banking services finds that the market is set to rise in the near term with the capacity constraints being faced by the pharmaceutical manufacturing companies and medical research institutes.
The global GMP cell banking services market is estimated to account for US$ 1,326.8 Mn in terms of value by the end of XXX.
An upcoming report on the global GMP cell banking services market by Transparency Market Research attempts to examine in depth the factors molding it. It studies both the market specific factors and macro fundamentals stoking or hindering market growth. The report also segments the GMP cell banking services market based on different parameters such as applications and geography. It then deep dives into each sector to understand which ones hold out maximum promise. The report also tries to figure out the current and future size of the market with respect to revenue generation.
A cell bank is a facility that stores cells collected from various body fluids and organ tissue so that they might be utilised in the future. Stored cells have precise characterization of the cell line, reducing the possibility of cross contamination. GMP cell banking services include the gathering, storing, characterisation, and testing of cell lines, tissues, and cells. According to the report, the rising popularity and accompanying demand for stem cell therapies would provide a significant boost to the global GMP cell banking services market.
No comments:
Post a Comment